paxilline has been researched along with globotriaosylceramide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, J; Katagiri, YU; Kiyokawa, N; Matsui, J; Okita, H; Okuda, K; Taguchi, T; Takenouchi, H | 1 |
1 other study(ies) available for paxilline and globotriaosylceramide
| Article | Year |
|---|---|
Shiga toxin binding to globotriaosyl ceramide induces intracellular signals that mediate cytoskeleton remodeling in human renal carcinoma-derived cells.
Topics: Actins; Carcinoma; Cell Line; Cell Line, Tumor; Cytoskeletal Proteins; Cytoskeleton; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Hyaluronan Receptors; Immunoblotting; Immunohistochemistry; Kidney; Kidney Neoplasms; Lipid Metabolism; Microscopy, Confocal; Microscopy, Fluorescence; Models, Biological; Paxillin; Phosphoproteins; Phosphorylation; Protein Binding; Protein-Tyrosine Kinases; RNA; Shiga Toxin; Shiga Toxin 1; Signal Transduction; Time Factors; Trihexosylceramides; Tubulin; Vimentin | 2004 |